Steven Cohen Bridge Bio Pharma, Inc. Put Options Transaction History

Point72 Asset Management, L.P.

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$23.91 - $31.3 $836,850 - $1.1 Million	35,000 New	35,000 $891,000
Q4 2023 Feb 14, 2024	BUY	$24.02 - $43.89 $1.2 Million - $2.19 Million	50,000 New	50,000 $2.02 Million
Q1 2023 May 15, 2023	BUY	$7.17 - $18.55 $250,950 - $649,250	35,000 New	35,000 $580,000
Q1 2022 May 16, 2022	SELL	$7.34 - $17.16 $383,148 - $895,752	-52,200 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$11.38 - $53.41 $594,036 - $2.79 Million	52,200 New	52,200 $871,000

290

170M

10.4M

2.37M

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $4.17B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.